Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB vs IV Lidocaine for Post-Thoracotomy Pain
NCT04221880Completed
- Sponsor
- Atatürk University
- Start
- Sep 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection and Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (3 arms), sponsored by Atatürk University. Primary endpoint: Total Opioid Consumption at 24 hours. Started Sep 2021; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injectionLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04221880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04221880.